Shanghai Fosun Pharmaceuticalgroupco Ltd Known As Fosun Pharmais A Global Healthcare Conglomerate Based In Shanghaichinafounded In 1994The Company Has Established Itself As A Leader In The Healthcare Sector With A Diverse Portfolio That Includes Pharmaceuticalsmedical Devicesdiagnosticsand Healthcare Servicesfosun Pharma Is Publicly Traded On The Shanghai Stock Exchange And The Hong Kong Stock Exchangewith A Market Capitalization Of Approximately Ay80 5 Billion As Of 2022 Fosun Pharma Develops And Commercializes A Range Of Productsincluding Small Molecule Drugsbiologicsand Genericsnotable Offerings Include Ganciclovirapproved For Treating Cytomegalovirus Retinitisthe Company Also Manufactures Surgical Equipmentdiagnostic Imaging Systemsand In Vitro Diagnostic Reagentsadditionallyfosun Pharma Operates Hospitals And Clinicsenhancing Its Healthcare Servicesthe Company Is Committed To Research And Developmentfocusing On Areas Such As Oncology And Immunologyand Has Expanded Its Global Presence Through Strategic Acquisitionsincluding Gland Pharma In India
